United States Drug of Abuse Testing Market Report 2017

Publisher Name :
Date: 10-Nov-2017
No. of pages: 100
Inquire Before Buying

In this report, the United States Drug of Abuse Testing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Drug of Abuse Testing in these regions, from 2012 to 2022 (forecast).

United States Drug of Abuse Testing market competition by top manufacturers/players, with Drug of Abuse Testing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Roche Holding Limited

- Quest Diagnostics

- Laboratory Corporation of America Holdings

- Alere Inc

- Abbott Laboratories

- Randox Laboratories

- Psychemedics Corporation

- Bio-Rad Laboratories

- Sonic Healthcare

- Thermo Fisher Scientific Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Onsite Screening Test

- Laboratory Drug Testing

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Drug of Abuse Testing for each application, including

- Urine

- Hair

- Saliva

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Drug of Abuse Testing Market Report 2017

Table of Contents
United States Drug of Abuse Testing Market Report 2017
1 Drug of Abuse Testing Overview
1.1 Product Overview and Scope of Drug of Abuse Testing
1.2 Classification of Drug of Abuse Testing by Product Category
1.2.1 United States Drug of Abuse Testing Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Drug of Abuse Testing Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Onsite Screening Test
1.2.4 Laboratory Drug Testing
1.3 United States Drug of Abuse Testing Market by Application/End Users
1.3.1 United States Drug of Abuse Testing Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Urine
1.3.3 Hair
1.3.4 Saliva
1.4 United States Drug of Abuse Testing Market by Region
1.4.1 United States Drug of Abuse Testing Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Drug of Abuse Testing Status and Prospect (2012-2022)
1.4.3 Southwest Drug of Abuse Testing Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Drug of Abuse Testing Status and Prospect (2012-2022)
1.4.5 New England Drug of Abuse Testing Status and Prospect (2012-2022)
1.4.6 The South Drug of Abuse Testing Status and Prospect (2012-2022)
1.4.7 The Midwest Drug of Abuse Testing Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Drug of Abuse Testing (2012-2022)
1.5.1 United States Drug of Abuse Testing Sales and Growth Rate (2012-2022)
1.5.2 United States Drug of Abuse Testing Revenue and Growth Rate (2012-2022)
2 United States Drug of Abuse Testing Market Competition by Players/Suppliers
2.1 United States Drug of Abuse Testing Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Drug of Abuse Testing Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Drug of Abuse Testing Average Price by Players/Suppliers (2012-2017)
2.4 United States Drug of Abuse Testing Market Competitive Situation and Trends
2.4.1 United States Drug of Abuse Testing Market Concentration Rate
2.4.2 United States Drug of Abuse Testing Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Drug of Abuse Testing Manufacturing Base Distribution, Sales Area, Product Type
3 United States Drug of Abuse Testing Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Drug of Abuse Testing Sales and Market Share by Region (2012-2017)
3.2 United States Drug of Abuse Testing Revenue and Market Share by Region (2012-2017)
3.3 United States Drug of Abuse Testing Price by Region (2012-2017)
4 United States Drug of Abuse Testing Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Drug of Abuse Testing Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Drug of Abuse Testing Revenue and Market Share by Type (2012-2017)
4.3 United States Drug of Abuse Testing Price by Type (2012-2017)
4.4 United States Drug of Abuse Testing Sales Growth Rate by Type (2012-2017)
5 United States Drug of Abuse Testing Sales (Volume) by Application (2012-2017)
5.1 United States Drug of Abuse Testing Sales and Market Share by Application (2012-2017)
5.2 United States Drug of Abuse Testing Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Drug of Abuse Testing Players/Suppliers Profiles and Sales Data
6.1 Roche Holding Limited
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Drug of Abuse Testing Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Roche Holding Limited Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Quest Diagnostics
6.2.2 Drug of Abuse Testing Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Quest Diagnostics Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Laboratory Corporation of America Holdings
6.3.2 Drug of Abuse Testing Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Laboratory Corporation of America Holdings Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Alere Inc
6.4.2 Drug of Abuse Testing Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Alere Inc Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Abbott Laboratories
6.5.2 Drug of Abuse Testing Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Abbott Laboratories Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Randox Laboratories
6.6.2 Drug of Abuse Testing Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Randox Laboratories Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Psychemedics Corporation
6.7.2 Drug of Abuse Testing Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Psychemedics Corporation Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bio-Rad Laboratories
6.8.2 Drug of Abuse Testing Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bio-Rad Laboratories Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Sonic Healthcare
6.9.2 Drug of Abuse Testing Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Sonic Healthcare Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Thermo Fisher Scientific Inc
6.10.2 Drug of Abuse Testing Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Thermo Fisher Scientific Inc Drug of Abuse Testing Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
7 Drug of Abuse Testing Manufacturing Cost Analysis
7.1 Drug of Abuse Testing Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drug of Abuse Testing
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drug of Abuse Testing Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drug of Abuse Testing Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Drug of Abuse Testing Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Drug of Abuse Testing Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Drug of Abuse Testing Sales Volume Forecast by Type (2017-2022)
11.3 United States Drug of Abuse Testing Sales Volume Forecast by Application (2017-2022)
11.4 United States Drug of Abuse Testing Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Drug of Abuse Testing
Figure United States Drug of Abuse Testing Market Size (K Pcs) by Type (2012-2022)
Figure United States Drug of Abuse Testing Sales Volume Market Share by Type (Product Category) in 2016
Figure Onsite Screening Test Product Picture
Figure Laboratory Drug Testing Product Picture
Figure United States Drug of Abuse Testing Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Drug of Abuse Testing by Application in 2016
Figure Urine Examples
Table Key Downstream Customer in Urine
Figure Hair Examples
Table Key Downstream Customer in Hair
Figure Saliva Examples
Table Key Downstream Customer in Saliva
Figure United States Drug of Abuse Testing Market Size (Million USD) by Region (2012-2022)
Figure The West Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drug of Abuse Testing Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Drug of Abuse Testing Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drug of Abuse Testing Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Drug of Abuse Testing Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Drug of Abuse Testing Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drug of Abuse Testing Sales Share by Players/Suppliers
Figure 2017 United States Drug of Abuse Testing Sales Share by Players/Suppliers
Figure United States Drug of Abuse Testing Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Drug of Abuse Testing Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Drug of Abuse Testing Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drug of Abuse Testing Revenue Share by Players/Suppliers
Figure 2017 United States Drug of Abuse Testing Revenue Share by Players/Suppliers
Table United States Market Drug of Abuse Testing Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Drug of Abuse Testing Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Drug of Abuse Testing Market Share of Top 3 Players/Suppliers
Figure United States Drug of Abuse Testing Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Drug of Abuse Testing Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Drug of Abuse Testing Product Category
Table United States Drug of Abuse Testing Sales (K Pcs) by Region (2012-2017)
Table United States Drug of Abuse Testing Sales Share by Region (2012-2017)
Figure United States Drug of Abuse Testing Sales Share by Region (2012-2017)
Figure United States Drug of Abuse Testing Sales Market Share by Region in 2016
Table United States Drug of Abuse Testing Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Drug of Abuse Testing Revenue Share by Region (2012-2017)
Figure United States Drug of Abuse Testing Revenue Market Share by Region (2012-2017)
Figure United States Drug of Abuse Testing Revenue Market Share by Region in 2016
Table United States Drug of Abuse Testing Price (USD/Pcs) by Region (2012-2017)
Table United States Drug of Abuse Testing Sales (K Pcs) by Type (2012-2017)
Table United States Drug of Abuse Testing Sales Share by Type (2012-2017)
Figure United States Drug of Abuse Testing Sales Share by Type (2012-2017)
Figure United States Drug of Abuse Testing Sales Market Share by Type in 2016
Table United States Drug of Abuse Testing Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Drug of Abuse Testing Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drug of Abuse Testing by Type (2012-2017)
Figure Revenue Market Share of Drug of Abuse Testing by Type in 2016
Table United States Drug of Abuse Testing Price (USD/Pcs) by Types (2012-2017)
Figure United States Drug of Abuse Testing Sales Growth Rate by Type (2012-2017)
Table United States Drug of Abuse Testing Sales (K Pcs) by Application (2012-2017)
Table United States Drug of Abuse Testing Sales Market Share by Application (2012-2017)
Figure United States Drug of Abuse Testing Sales Market Share by Application (2012-2017)
Figure United States Drug of Abuse Testing Sales Market Share by Application in 2016
Table United States Drug of Abuse Testing Sales Growth Rate by Application (2012-2017)
Figure United States Drug of Abuse Testing Sales Growth Rate by Application (2012-2017)
Table Roche Holding Limited Basic Information List
Table Roche Holding Limited Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Holding Limited Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Roche Holding Limited Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Roche Holding Limited Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Quest Diagnostics Basic Information List
Table Quest Diagnostics Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Quest Diagnostics Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Quest Diagnostics Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Quest Diagnostics Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Laboratory Corporation of America Holdings Basic Information List
Table Laboratory Corporation of America Holdings Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Laboratory Corporation of America Holdings Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Laboratory Corporation of America Holdings Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Laboratory Corporation of America Holdings Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Alere Inc Basic Information List
Table Alere Inc Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alere Inc Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Alere Inc Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Alere Inc Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Laboratories Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Randox Laboratories Basic Information List
Table Randox Laboratories Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Randox Laboratories Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Randox Laboratories Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Randox Laboratories Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Psychemedics Corporation Basic Information List
Table Psychemedics Corporation Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Psychemedics Corporation Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Psychemedics Corporation Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Psychemedics Corporation Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Bio-Rad Laboratories Basic Information List
Table Bio-Rad Laboratories Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Bio-Rad Laboratories Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Bio-Rad Laboratories Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Sonic Healthcare Basic Information List
Table Sonic Healthcare Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sonic Healthcare Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Sonic Healthcare Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Sonic Healthcare Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Inc Basic Information List
Table Thermo Fisher Scientific Inc Drug of Abuse Testing Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Inc Drug of Abuse Testing Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Inc Drug of Abuse Testing Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Inc Drug of Abuse Testing Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug of Abuse Testing
Figure Manufacturing Process Analysis of Drug of Abuse Testing
Figure Drug of Abuse Testing Industrial Chain Analysis
Table Raw Materials Sources of Drug of Abuse Testing Major Players/Suppliers in 2016
Table Major Buyers of Drug of Abuse Testing
Table Distributors/Traders List
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Drug of Abuse Testing Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Drug of Abuse Testing Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Drug of Abuse Testing Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Drug of Abuse Testing Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drug of Abuse Testing Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global In-Vitro Diagnostics (IVD) Market Size, Status and Forecast 2022
    Published: 17-Nov-2017        Price: US 3300 Onwards        Pages: 100
    This report studies the global In-Vitro Diagnostics (IVD) market, analyzes and researches the In-Vitro Diagnostics (IVD) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Roche - Siemens - Danaher - Abbott - BD - Alere - SYSMEX - BioMerieux - J&J - BIO-RAD - Hologic - KHB Market segment by Re......
  • Therapeutic Drug Monitoring (TDM) Market 2021: US, Europe, Japan--Supplier Shares, Competitive Strategies, Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 8500 Onwards        Pages: 0
    Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 313-page report from VPGMarketResearch.com contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and m......
  • France Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Germany Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Pr......
  • Italy Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • Japan Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2750 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/......
  • Spain Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation ReviewReview
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/P......
  • UK Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 2450 Onwards        Pages: 0
    This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Proca......
  • US Therapeutic Drug Monitoring (TDM) Market 2021: Supplier Shares, Competitive Strategies, Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 0
    This new 249-page report from VPGMarketResearch.com provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procai......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs